AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32169111
Drug: Active stimulation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active stimulation plus treatment as usual (TAU)
Trial: 33615630
Drug: Prucalopride (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride (2 mg)
Trial: 33947442
Drug: Continuous erector
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous erector spinae plane block plus intravenous patient‐controlled analgesia with piritramide
Trial: 38369528
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution (NSS)
Trial: 33944698
Drug: Exergaming using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exergaming using the Playpulse platform for a minimum of 45 minutes twice weekly for eight weeks
Trial: 34269974
Drug: Sodium iron
RxNorm normalized name: Sodium iron EDTA
DrugBank: Sodium feredetate (DB13381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium iron EDTA (NaFeEDTA) salt-enriched fish powder (250 mg/100 g)
Trial: 37830344
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin
Trial: 32662827
Drug: MB with
RxNorm normalized name: Ionosol-MB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MB with oral irrigation (Waterpik [WP], experimental)
Trial: 35940873
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose intravenous paracetamol (10 mg/kg/dose 6 hourly for 72 hours)
Trial: 33263237
Drug: Stainless steel
RxNorm normalized name: stainless steel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stainless steel wire fixation and BM injection at the fracture line
Trial: 33263237
Drug: Plate fixation
RxNorm normalized name: phenylephrine hydrochloride Ophthalmic Solution [AK-Dilate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plate fixation and BM injection at the fracture line
Trial: 33263237
Drug: Stainless steel
RxNorm normalized name: stainless steel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stainless steel bone wire fixation and placebo saline injection at the fracture line
Trial: 36070920
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (DAPT) using cilostazol
Trial: 37301768
Drug: Intensive antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive antihypertensive treatment
Trial: 35450161
Drug: Vigorous walking
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vigorous walking thrice weekly (VIG × 3/week)
Trial: 36030400
Drug: Standard-dose quadrivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose quadrivalent inactivated vaccine administered in the outpatient setting 30 days after randomization
Trial: 33459175
Drug: Photobiomodulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation therapy (PBMT)
Trial: 32212483
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (100 mg, tid) for 3 months (Control)
Trial: 37148183
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy for insomnia (CBT-I)
Trial: 34916467
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg rifampin
Trial: 37166257
Drug: Dexamethasone 1
RxNorm normalized name: dexamethasone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 1 mg/kg
Trial: 34704709
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% plus 100 µg dexmedetomidine (1 mL)
Trial: 34021607
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg biperiden
Trial: 32513308
Drug: anti-SARS-CoV-2 human
RxNorm normalized name: ANTI-SARS-COV-2 HUMAN IMMUNOGLOBULIN INTRAVENOUS (TC BOVINE-DERIVED),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: anti-SARS-CoV-2 human convalescent plasma (200 - 250 mL)
Trial: 39669005
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy intervention
Trial: 39746515
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate nasal spray (MFNS)
Trial: 33120808
Drug: Ramelteon (Rozerem)
RxNorm normalized name: Ramelteon
DrugBank: Ramelteon (DB00980)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramelteon (Rozerem) administered 7 days prior and 7 days post-surgery
Trial: 33625666
Drug: Pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatment only (Control)
Trial: 32798723
Drug: Lidocaine 2%
RxNorm normalized name: LIDOCAINE 2% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 2% (10 mL) added to 1000 mL saline solution
Trial: 32640940
Drug: Goal-Directed Hemodynamic
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-Directed Hemodynamic Therapy (GDHT)
Trial: 33757688
Drug: Botulinum toxin-A
RxNorm normalized name: Botulinum toxin A
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: Botulinum toxin-A (BTX-A) injection into masticatory muscles (masseter and temporalis) 2 weeks prior to surgery
Trial: 33757688
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline injection into masticatory muscles (masseter and temporalis) 2 weeks prior to surgery
Trial: 34894328
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy
Trial: 34360494
Drug: Oxytocin administration
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin administration to induce or stimulate labour
Trial: 38754891
Drug: Traditional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional treatment
Trial: 35182213
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received 40 ml of 0.9% normal saline
Trial: 32150492
Drug: Epinephrine HFA
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine HFA MDI at doses above 125 μg
Trial: 36259487
Drug: Ultrasound-guided platelet-rich
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided platelet-rich plasma (PRP) injection combined with drugs
Trial: 36259487
Drug: Ultrasound-guided PRP
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided PRP injection combined with drugs
Trial: 32021411
Drug: Meloxicam IV
RxNorm normalized name: Meloxicam
DrugBank: Meloxicam (DB00814)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meloxicam IV 30 mg
Trial: 34480579
Drug: Suvorexant 150
RxNorm normalized name: Suvorexant
DrugBank: Suvorexant (DB09034)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suvorexant 150 mg
Trial: 32081787
Drug: T cell
RxNorm normalized name: CD4CAR T cells
DrugBank: Anti-CD4 CAR T-cell therapy (DB17281)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T cell receptor (TCR) repertoire analysis in patients with steroid nonresponsive aGVHD
Trial: 32074767
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist
Trial: 34922258
Drug: High flow
RxNorm normalized name: Blood Set High Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High flow nasal cannula (HFNC) at 40 L/min
Trial: 35701011
Drug: Risankizumab (RZB)
RxNorm normalized name: risankizumab
DrugBank: Risankizumab (DB14762)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Risankizumab (RZB) 150 mg
Trial: 38434770
Drug: Crizotinib 250
RxNorm normalized name: crizotinib 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crizotinib 250 mg twice daily
Trial: 34882500
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg once daily bupropion
Trial: 35642832
Drug: Fibrinogen administration
RxNorm normalized name: fibrinogen
DrugBank: Fibrinogen human (DB09222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinogen administration
Trial: 33849683
Drug: Amphetamine 10
RxNorm normalized name: amphetamine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amphetamine 10 mg
Trial: 35256150
Drug: Intravenous ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ferric derisomaltose 1000 mg and darbepoetin 200 μg subcutaneously
Trial: 35527666
Drug: Step-up medium
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Step-up medium dose of ICS
Trial: 35576279
Drug: Lipid-based nutritional
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutritional supplement (LNS) (535 kcal)
Trial: 32747522
Drug: Fremanezumab quarterly
RxNorm normalized name: Fremanezumab
DrugBank: Fremanezumab (DB14041)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fremanezumab quarterly (675 mg at baseline, placebo at weeks 4 and 8)
Trial: 39327857
Drug: Tenofovir disoproxil
RxNorm normalized name: Tenofovir Disoproxil
DrugBank: Tenofovir disoproxil (DB00300)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tenofovir disoproxil fumarate (TDF) 300 mg/day
Trial: 33605002
Drug: Intralesional platelet
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional platelet rich plasma (PRP) injection
Trial: 33605002
Drug: Intralesional triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intralesional triamcinolone acetonide (TAC) injection
Trial: 38215286
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets
Trial: 32501897
Drug: Gene therapy
RxNorm normalized name: E1A gene therapy
DrugBank: RGG0853 (DB18669)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gene therapy for Lebers Congenital Amaurosis
Trial: 35122766
Drug: Clinically adjusted
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinically adjusted (CA) maintenance therapy
Trial: 33762031
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D insufficient (25(OH)D < 30 ng/mL)
Trial: 33211152
Drug: Lower dosage
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dosage of oral spermidine supplementation
Trial: 32997098
Drug: Low-dose rivaroxaban
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rivaroxaban and aspirin
Trial: 36121246
Drug: Pulmonary artery
RxNorm normalized name: Pulmonary artery blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmonary artery denervation (PADN) plus a phosphodiesterase‐5 inhibitor
Trial: 36121246
Drug: Sham procedure
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Sham procedure plus a phosphodiesterase‐5 inhibitor
Trial: 37105885
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion
Trial: 32459423
Drug: Elagolix plus
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Elagolix plus add-back therapy
Trial: 39439530
Drug: Rivaroxaban plus
RxNorm normalized name: Rivaroxaban
DrugBank: Rivaroxaban (DB06228)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rivaroxaban plus aspirin
Trial: 36275695
Drug: Convalescent plasma
RxNorm normalized name: Convalescent plasma
DrugBank: COVID-19 convalescent plasma (DB15692)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Convalescent plasma (CCP) with standard treatment
Trial: 34228889
Drug: Systemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic therapy (ST) discontinued
Trial: 32838476
Drug: Outpatient therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient therapy (higher, rapid class)
Trial: 34819017
Drug: Quarterly fremanezumab
RxNorm normalized name: Fremanezumab
DrugBank: Fremanezumab (DB14041)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Quarterly fremanezumab (675 mg)
Trial: 35243870
Drug: Antiplatelet drugs
RxNorm normalized name: simethicone
DrugBank: Simethicone (DB09512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet drugs
Trial: 33683087
Drug: Topical imiquimod
RxNorm normalized name: imiquimod Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical imiquimod 5% cream
Trial: 34917633
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone (MP) 0.5 mg/kg, two times daily for 5 days
Trial: 33673371
Drug: Intravenous Ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous Ferric Carboxy-Maltose (FCM) 1000 mg at baseline
Trial: 32374030
Drug: Single-component tablets
RxNorm normalized name: 1,3-beta-glucan synthase component FKS1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-component tablets of macitentan (10 mg) and tadalafil (40 mg)
Trial: 32764775
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy
Trial: 35640529
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg oral THC
Trial: 34261530
Drug: Sham intradermal
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham intradermal acupuncture (sham IA) treatment
Trial: 35560470
Drug: Dietary nitrate
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary nitrate supplements (140 ml of beetroot juice; 800 mg nitrate/day)
Trial: 37652258
Drug: Tanezumab 5
RxNorm normalized name: tanezumab
DrugBank: Tanezumab (DB12335)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tanezumab 5 mg
Trial: 36789481
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch
Trial: 36224090
Drug: Traditional Oral
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional Oral Hygiene Instruction (OHI)
Trial: 39009776
Drug: Beta-blockers
RxNorm normalized name: BETA-BLOCKERS,TOPICAL OPHTHALMIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers
Trial: 32121000
Drug: Hb threshold
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hb threshold <12.35 g/dL
Trial: 32363493
Drug: Alirocumab 75
RxNorm normalized name: alirocumab 75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab 75 mg every 2 weeks (Q2W)
Trial: 34036357
Drug: 350 g
RxNorm normalized name: ALCOHOL 350 g in 500 mL TOPICAL GEL [C2V LINE CLEAR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 g Greek yogurt
Trial: 35224756
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of m3, Fn and Ch at follow-up
Trial: 34119499
Drug: Prophylactic cefazolin
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prophylactic cefazolin 2 g IV (Group A)
Trial: 32779728
Drug: Intravenous hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous hydrocortisone 200 mg daily for 7 days
Trial: 33905902
Drug: Sequential administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential administration of 2% lidocaine and 0.5% bupivacaine
Trial: 32089456
Drug: Proprotein convertase
RxNorm normalized name: Proprotein convertase 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proprotein convertase subtilisin kexin type 9 inhibitors
Trial: 37440232
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual only
Trial: 33559248
Drug: Antibody testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibody testing
Trial: 35068061
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 600 mg twice daily + tamsulosin 0.4 mg once daily
Trial: 34109243
Drug: Pirfenidone 2403
RxNorm normalized name: Pirfenidone
DrugBank: Pirfenidone (DB04951)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pirfenidone 2403 mg/day
Trial: 32367867
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg (Group O)
Trial: 32040523
Drug: Higher number
RxNorm normalized name: Derma Numb
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher number of medications per day
Trial: 34930617
Drug: veliparib during
RxNorm normalized name: veliparib
DrugBank: Veliparib (DB07232)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: veliparib during chemotherapy followed by placebo maintenance (veliparib-combination only)
Trial: 37460024
Drug: Subcutaneous immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous immunotherapy (SCIT)
Trial: 39448207
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy
Trial: 34922302
Drug: Cognitive Behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavior Sex Therapy (CBST)
Trial: 32588127
Drug: No beta-blockers
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No beta-blockers
Trial: 35690827
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily injections (MDI)
Trial: 35338177
Drug: Milvexian 50
RxNorm normalized name: Milvexian
DrugBank: Milvexian (DB16233)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milvexian 50 mg daily for 14 days
Trial: 38918871
Drug: Abatacept (subcutaneous)
RxNorm normalized name: Abatacept
DrugBank: Abatacept (DB01281)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Abatacept (subcutaneous)
Trial: 32756078
Drug: Sancai powder
RxNorm normalized name: Sanchi
DrugBank: Panax notoginseng root (DB14304)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sancai powder (SC) combined with western medicine
Trial: 36221341
Drug: Conventional western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional western medicine
Trial: 35274092
Drug: Low-dose azathioprine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose azathioprine combined with allopurinol
Trial: 34669318
Drug: Prophylactic Magnesium
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic Magnesium supplementation (oral for 5 days before surgery)
Trial: 34215673
Drug: 68Ga-satoreotide trizoxetan
RxNorm normalized name: 68Ga-DOTATOC
DrugBank: Dotatate gallium Ga-68 (DB13925)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 68Ga-satoreotide trizoxetan at a peptide mass of 5-20 µg and 30-45 µg with radioactivity ranges of 40-80, 100-140, or 160-200 MBq
Trial: 38850034
Drug: Sildenafil 100
RxNorm normalized name: sildenafil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 100 mg
Trial: 36041791
Drug: IgAN patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgAN patients (treatment naive)
Trial: 34541479
Drug: ALRV5XR treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ALRV5XR treatment
Trial: 35397306
Drug: Myofascial therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myofascial therapy
Trial: 34265462
Drug: ChAdOx1 nCoV-19
RxNorm normalized name: ChAdOx1 nCoV-19
DrugBank: AstraZeneca COVID-19 Vaccine (DB15656)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ChAdOx1 nCoV-19 (1 dose)